BET-BAY 002

CAS No. 1588521-78-1

BET-BAY 002( BET-BAY-002 )

Catalog No. M12268 CAS No. 1588521-78-1

BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 312 Get Quote
50MG 1341 Get Quote
100MG 1791 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BET-BAY 002
  • Note
    Research use only, not for human use.
  • Brief Description
    BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.
  • Description
    BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BET-BAY-002
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1588521-78-1
  • Formula Weight
    403.8642
  • Molecular Formula
    C22H18ClN5O
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=NN=C2N1C3=CC=CC=C3C(=CC2CC4=NN=C(O4)C)C5=CC=C(C=C5)Cl
  • Chemical Name
    4H-[1,2,4]Triazolo[4,3-a][1]benzazepine, 6-(4-chlorophenyl)-1-methyl-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-, (4R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BET inhibitor CF53

    BET inhibitor CF53 is a highly potent, orally active inhibitor of bromodomain and extra-terminal (BET) with Ki of <1 nM (BRD4 BD1).

  • PLX51107

    PLX51107 is a novel structurally distinct BET bromodomain inhibitor that inhibits all four BET family proteins.

  • CeMMEC2

    CeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM.